INTRODUCTION: Previous studies have shown the existence of either cellular or humoral MBP-reactive elements up to 5 years after spinal cord injury (SCI), but not the presence of both after 10 years. MATERIALS AND METHODS: Twelve SCI patients, with more than 10 years of evolution, and 18 healthy blood donors were studied. Lymphocyte proliferation (colorimetric-BrdU ELISA assay) and antibody titers against MBP (ELISA Human IgG MBP-specific assay) were assessed. RESULTS: SCI patients presented a significant T-cell proliferation against MBP (lymphocyte proliferation index: 3.7 ± 1.5, mean ± SD) compared to control individuals (0.7 ± 0.3; P < 0.001). Humoral response analysis yielded a significant difference (P < 0.0001) between the antibody titers of controls and SCI patients. A significant correlation between cellular and humoral responses was observed. Finally, patients with an ASIA B presented the highest immune responses. CONCLUSION: This work demonstrates, for the first time, the existence of both cellular and humoral responses against MBP in the chronic stages (>10 years) of injury.
INTRODUCTION: Previous studies have shown the existence of either cellular or humoral MBP-reactive elements up to 5 years after spinal cord injury (SCI), but not the presence of both after 10 years. MATERIALS AND METHODS: Twelve SCI patients, with more than 10 years of evolution, and 18 healthy blood donors were studied. Lymphocyte proliferation (colorimetric-BrdU ELISA assay) and antibody titers against MBP (ELISA Human IgG MBP-specific assay) were assessed. RESULTS: SCI patients presented a significant T-cell proliferation against MBP (lymphocyte proliferation index: 3.7 ± 1.5, mean ± SD) compared to control individuals (0.7 ± 0.3; P < 0.001). Humoral response analysis yielded a significant difference (P < 0.0001) between the antibody titers of controls and SCI patients. A significant correlation between cellular and humoral responses was observed. Finally, patients with an ASIA B presented the highest immune responses. CONCLUSION: This work demonstrates, for the first time, the existence of both cellular and humoral responses against MBP in the chronic stages (>10 years) of injury.
Authors: K C Hayes; T C L Hull; G A Delaney; P J Potter; K A J Sequeira; K Campbell; P G Popovich Journal: J Neurotrauma Date: 2002-06 Impact factor: 5.269
Authors: Antonio Ibarra; Elisa García; Nayeli Flores; Susana Martiñón; Rafael Reyes; María G Campos; Marcial Maciel; H Mestre Journal: Neurosci Lett Date: 2010-04-08 Impact factor: 3.046
Authors: K Kil; Y C Zang; D Yang; J Markowski; G S Fuoco; G C Vendetti; V M Rivera; J Z Zhang Journal: J Neuroimmunol Date: 1999-08-03 Impact factor: 3.478
Authors: T Bucky Jones; D Michele Basso; Ajeet Sodhi; Jonathan Z Pan; Ronald P Hart; Robert C MacCallum; Sunhee Lee; Caroline C Whitacre; Phillip G Popovich Journal: J Neurosci Date: 2002-04-01 Impact factor: 6.167
Authors: Antonio Ibarra; Dolores Correa; Kaethe Willms; Marie Therese Merchant; Gabriel Guizar-Sahagún; Israel Grijalva; Ignacio Madrazo Journal: Brain Res Date: 2003-07-25 Impact factor: 3.252
Authors: Jonathan Kipnis; Uri Nevo; David Panikashvili; Alexander Alexandrovich; Eti Yoles; Solange Akselrod; Esther Shohami; Michal Schwartz Journal: J Neurotrauma Date: 2003-06 Impact factor: 5.269
Authors: A L Cox; A J Coles; J Nortje; P G Bradley; D A Chatfield; S J Thompson; D K Menon Journal: J Neuroimmunol Date: 2006-03-06 Impact factor: 3.478
Authors: Benedikt Brommer; Odilo Engel; Marcel A Kopp; Ralf Watzlawick; Susanne Müller; Harald Prüss; Yuying Chen; Michael J DeVivo; Felix W Finkenstaedt; Ulrich Dirnagl; Thomas Liebscher; Andreas Meisel; Jan M Schwab Journal: Brain Date: 2016-01-10 Impact factor: 13.501
Authors: Georgene W Hergenroeder; John B Redell; H Alex Choi; Lisa Schmitt; William Donovan; Gerard E Francisco; Karl Schmitt; Anthony N Moore; Pramod K Dash Journal: J Neurotrauma Date: 2018-07-05 Impact factor: 5.269
Authors: Jonah W Saltzman; Ricardo A Battaglino; Loise Salles; Prateek Jha; Supreetha Sudhakar; Eric Garshick; Helen L Stott; Ross Zafonte; Leslie R Morse Journal: J Neurotrauma Date: 2013-03-28 Impact factor: 5.269